413 related articles for article (PubMed ID: 1475386)
1. [Diagnostic value of antibodies against HIV-1 proteins in seropositive drug addicts tested by the western blotting method].
Swiderska H; Kalinowska B
Przegl Epidemiol; 1992; 46(1-2):19-25. PubMed ID: 1475386
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
[TBL] [Abstract][Full Text] [Related]
4. Gp160 of commercial HIV western blots is not gp160env. Should criteria for seropositivity be revised?
Fenouillet E; Blanes N; Gluckman JC
AIDS; 1991 Jun; 5(6):770. PubMed ID: 1883550
[No Abstract] [Full Text] [Related]
5. Significance of the positivity of some ELISA tests different as concerning the antigenic source in interpreting the western blot indeterminate sera in monitoring the epidemiology of high risk populations.
Neguţ E; Mazilu E; Băncescu G
Roum Arch Microbiol Immunol; 1992; 51(1-2):101-13. PubMed ID: 1457820
[TBL] [Abstract][Full Text] [Related]
6. Enzyme immunoassay using native envelope glycoprotein (gp160) for detection of human immunodeficiency virus type 1 antibodies.
Nair BC; Ford G; Kalyanaraman VS; Zafari M; Fang C; Sarngadharan MG
J Clin Microbiol; 1994 Jun; 32(6):1449-56. PubMed ID: 8077388
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 neutralizing antibodies in urine from seropositive individuals.
Cao YZ; Friedman-Kien AE; Mirabile M; Li XL; Alam M; Dieterich D; Ho DD
J Acquir Immune Defic Syndr (1988); 1990; 3(3):195-9. PubMed ID: 1968094
[TBL] [Abstract][Full Text] [Related]
8. New tests produced by Organon Teknika for the diagnosis of antibodies to HIV-1 and HIV-2.
Chantrain C
Przegl Epidemiol; 1992; 46(1-2):3-10. PubMed ID: 1475387
[No Abstract] [Full Text] [Related]
9. Quantitative analysis of human immunodeficiency virus type 1 antibody reactivity by western immunoblots: evaluation of relative antibody levels in seropositive individuals and mothers.
Geffin RB; Lai SH; Hutto C; Scott GB; Scott WA; Master M; Parks WP
J Infect Dis; 1992 Jan; 165(1):111-8. PubMed ID: 1727880
[TBL] [Abstract][Full Text] [Related]
10. [Study on the indeterminate results of characterization and verification of HIV antibody from Western blot test].
Bao ZY; Liu YJ; Wang HY; Wang QL; Luo Q; Liu YD; Ma F; Xing YC; Tong YG; Li JY
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 May; 29(5):478-81. PubMed ID: 18956682
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of HIV-1 and HIV-2 indeterminate western blot patterns.
Ayisi NK; Aidoo M
West Afr J Med; 1994; 13(3):164-7. PubMed ID: 7841107
[TBL] [Abstract][Full Text] [Related]
12. Frequent detection of HIV- and IgG-specific IgM and IgA antibodies in HIV-positive cord-blood sera: fine analysis by western blot.
Schüpbach J; Wunderli W; Kind C; Kernen R; Baumgartner A; Tomasik Z
AIDS; 1989 Sep; 3(9):583-9. PubMed ID: 2506903
[TBL] [Abstract][Full Text] [Related]
13. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
[TBL] [Abstract][Full Text] [Related]
14. The association of "standard ELISA" and HIV (env) ELISA for detection and confirmation of HIV antibodies in human sera.
Filice G; Soldini L; Orsolini P; Campisi D; Chiesa A; Gulminetti R; Achilli G; Cattaneo E
Microbiologica; 1991 Jan; 14(1):9-13. PubMed ID: 2067417
[TBL] [Abstract][Full Text] [Related]
15. Radioimmune western blotting in comparison with conventional western blotting, second and third generation ELISA assays for the serodiagnosis of HIV-1 infection.
Portincasa P; Conti G; Zannino T; Visalli S; Chezzi C
New Microbiol; 1994 Jul; 17(3):169-76. PubMed ID: 7968651
[TBL] [Abstract][Full Text] [Related]
16. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.
Dis Markers; 1991; 9(1):51. PubMed ID: 1742945
[No Abstract] [Full Text] [Related]
17. HIV experimental vaccines based on the iscom technology using envelope and GAG gene products.
Akerblom L; Nara P; Dunlop N; Putney S; Morein B
Biotechnol Ther; 1993; 4(3-4):145-61. PubMed ID: 8292967
[TBL] [Abstract][Full Text] [Related]
18. Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials Network.
Viscidi R; Ellerbeck E; Garrison L; Midthun K; Clements ML; Clayman B; Fernie B; Smith G
AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1251-6. PubMed ID: 1706607
[TBL] [Abstract][Full Text] [Related]
19. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.
Zwart G; van der Hoek L; Valk M; Cornelissen MT; Baan E; Dekker J; Koot M; Kuiken CL; Goudsmit J
Virology; 1994 Jun; 201(2):285-93. PubMed ID: 7514319
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G
AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
